PS 10-02 ESTROGEN-PROGESTIN ORAL CONTRACEPTIVE CAUSES DYSLIPIDEMIA, β-CELL DYSFUNCTION AND ELEVATED PROFIBROTIC MARKERS THROUGH MINERALOCORTICOID RECEPTOR ACTIVATION
Oluwaseun Adeyanju(The University of Texas Health Science Center at Tyler), Ayodele Olufemi Soladoye(University of Ilorin), Lawrence A. Olatunji(Kyungpook National University), Aminat Akinade(University of Ilorin), Olugbenga Samuel Michael(University of Ilorin), Olaniyi A. Soetan(University of Ilorin), Inkyeom Kim(Kyungpook National University), Taofeek O. Usman(University of Pittsburgh)
Cited by 0
Related Papers
Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis
|Journal of Clinical Investigation|2022|57
Beta-cell compensation and gestational diabetes
|Journal of Biological Chemistry|2023|51
Histone Deacetylase 3 and 4 Complex Stimulates the Transcriptional Activity of the Mineralocorticoid Receptor
|PLoS ONE|2015|37
Activation of cardiac renin–angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder
|Archives of Physiology and Biochemistry|2016|17
Transfer of Th17 from Adult Spontaneous Hypertensive Rats Accelerates Development of Hypertension in Juvenile Spontaneous Hypertensive Rats
|BioMed Research International|2021|17